Table 1.

Summary of results from metabolomic investigations of serum/plasma from case-control studies, showing numbers of subjects, discriminating features and identified features, as reported by (Nordstrom & Lewensohn 2010).

Disease	Disease class	No. of subjects	Discrim. features	Ident. features	Reference
Huntington's disease	Neurologic	50	15	15	(Underwood et al. 2006)
Parkinson's disease	Neurologic	88	17	3	(Bogdanov et al. 2008)
Motor neuron disease	Neurologic	58	76	0	(Rozen et al. 2005)
Celiac disease	Immunologic	68	16	16	(Bertini et al. 2009)
Ischemia	Cardiovascular	31	5	5	(Barba et al. 2008)
Myocardial injury	Cardiovascular	72	13	13	(Lewis et al. 2008)
Myocardial ischemia	Cardiovascular	36	23	6	(Sabatine et al. 2005)
Myocardial ischemia	Cardiovascular	39	4	4	(Lin et al. 2009)
Renal cell carcinoma	Cancer	129	14	14	(Gao et al. 2008)
Pancreatic cancer	Cancer	190	3	3	(Beger et al. 2006)
Prostate cancer	Cancer	220	10	10	(Osl et al. 2008)